CN Stock MarketDetailed Quotes

300482 Guangzhou Wondfo Biotech

Watchlist
  • 24.42
  • +0.20+0.83%
Market Closed Nov 29 15:00 CST
11.76BMarket Cap22.44P/E (TTM)

Guangzhou Wondfo Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
8.83%2.18B
5.82%1.58B
3.54%861.09M
-51.33%2.76B
-57.32%2B
-63.09%1.49B
-68.32%831.63M
69.01%5.68B
87.32%4.7B
117.30%4.03B
Operating revenue
8.83%2.18B
5.82%1.58B
3.54%861.09M
-51.33%2.76B
-57.32%2B
-63.09%1.49B
-68.32%831.63M
69.01%5.68B
87.32%4.7B
117.30%4.03B
Other operating revenue
----
-50.13%1.92M
----
-24.25%5.22M
----
-41.70%3.85M
----
-3.11%6.89M
----
38.95%6.6M
Total operating cost
6.21%1.72B
3.35%1.18B
0.28%609.78M
-47.01%2.29B
-51.44%1.62B
-57.58%1.15B
-59.46%608.06M
57.09%4.33B
75.23%3.33B
112.25%2.7B
Operating cost
7.08%797.67M
3.53%561.7M
0.54%290.15M
-62.22%1.03B
-65.58%744.9M
-69.04%542.55M
-69.54%288.59M
96.02%2.74B
151.46%2.16B
202.20%1.75B
Operating tax surcharges
28.71%7.25M
22.26%5.17M
48.62%3.04M
-31.63%12.17M
-47.30%5.63M
-50.56%4.23M
-42.78%2.04M
77.41%17.8M
58.25%10.69M
70.24%8.55M
Operating expense
1.30%472.01M
0.95%318.5M
9.45%159.81M
-30.08%649.99M
-30.87%465.93M
-43.47%315.5M
-58.21%146.02M
44.28%929.61M
24.42%673.97M
53.54%558.11M
Administration expense
1.65%153.22M
1.07%107.38M
-8.68%58.49M
-0.32%227.13M
-23.38%150.73M
-29.74%106.24M
-12.89%64.05M
-14.32%227.85M
5.56%196.72M
24.46%151.23M
Financial expense
227.46%14.4M
56.70%-5.8M
-155.96%-7.25M
-817.68%-6.41M
60.48%-11.3M
-88.51%-13.39M
67.60%12.96M
-101.43%-697.96K
-209.34%-28.59M
-132.07%-7.1M
-Interest expense (Financial expense)
0.66%21.63M
2.58%15.09M
-10.42%7.14M
-7.99%29.93M
-4.81%21.49M
-0.04%14.71M
6.85%7.98M
17.21%32.53M
4.79%22.58M
3.27%14.71M
-Interest Income (Financial expense)
-7.43%-16.32M
-45.93%-13.18M
-108.50%-5.27M
-435.67%-27.61M
-265.23%-15.19M
-121.92%-9.03M
-224.51%-2.53M
-70.87%-5.15M
-150.37%-4.16M
-205.02%-4.07M
Research and development
4.51%271.18M
3.45%197.31M
11.80%105.55M
-9.75%378M
-16.14%259.47M
-19.91%190.74M
-20.18%94.4M
7.09%418.84M
11.85%309.4M
31.82%238.15M
Credit Impairment Loss
-1,943.83%-18.1M
-845.04%-15.27M
-368.29%-8.46M
92.91%-1.5M
92.74%-885.39K
85.44%-1.62M
97.79%-1.81M
4.18%-21.14M
8.93%-12.2M
10.97%-11.1M
Asset Impairment Loss
----
----
----
85.41%-11.52M
----
----
----
-1,244.43%-78.97M
----
----
Other net revenue
-55.95%32.47M
-64.29%16.23M
-88.63%962.56K
357.37%78.88M
13.06%73.72M
27.21%45.45M
110.99%8.47M
-80.23%17.25M
-19.05%65.2M
-36.55%35.73M
Fair value change income
71.62%24.42M
5,272.86%15.57M
--867.58K
15.51%14.8M
281.58%14.23M
-98.04%289.84K
----
21.42%12.81M
--3.73M
--14.81M
Invest income
-92.58%1.96M
-105.45%-1.21M
81.08%2.96M
-47.97%31.1M
-23.74%26.48M
83.34%22.22M
-39.81%1.63M
25.92%59.77M
-27.69%34.72M
-60.16%12.12M
-Including: Investment income associates
-305.48%-12.42M
-580.74%-7.34M
-669.69%-3M
-233.77%-4.33M
-2,264.09%-3.06M
73.99%-1.08M
66.39%-390.3K
156.38%3.24M
-96.20%141.57K
-248.87%-4.14M
Asset deal income
1,434.58%736.98K
----
----
100.77%80.14K
-8,757.56%-55.22K
-4,937.69%-55.22K
---59.91K
-183,304.02%-10.4M
-99.68%637.85
-99.28%1.14K
Other revenue
-30.95%23.45M
-30.32%17.14M
-35.62%5.6M
-16.77%45.92M
-12.83%33.95M
23.68%24.6M
315.37%8.7M
-3.45%55.17M
-14.82%38.95M
-47.91%19.89M
Operating profit
7.64%498.11M
4.90%407.22M
8.72%252.27M
-59.85%549.14M
-67.76%462.77M
-71.63%388.22M
-77.86%232.04M
97.68%1.37B
108.18%1.44B
113.82%1.37B
Add:Non operating Income
-49.40%1.07M
-44.42%705.83K
-65.58%228.83K
16.58%3.55M
126.48%2.12M
168.03%1.27M
10.43%664.73K
8.17%3.04M
-6.61%935.96K
-41.79%473.82K
Less:Non operating expense
17.45%6.34M
-10.66%2.58M
-24.54%897.9K
90.81%11.92M
-11.85%5.4M
0.41%2.89M
31.16%1.19M
-56.07%6.25M
43.14%6.13M
4.51%2.88M
Total profit
7.26%492.84M
4.85%405.35M
8.68%251.6M
-60.37%540.76M
-67.87%459.49M
-71.70%386.6M
-77.91%231.51M
100.52%1.36B
108.42%1.43B
114.10%1.37B
Less:Income tax cost
-14.21%53.02M
-12.54%47.03M
6.35%31.16M
-69.42%53.33M
-68.39%61.8M
-71.82%53.77M
-79.95%29.3M
264.04%174.41M
228.27%195.48M
138.34%190.8M
Net profit
10.59%439.82M
7.66%358.31M
9.02%220.44M
-59.04%487.43M
-67.79%397.69M
-71.68%332.82M
-77.57%202.21M
88.14%1.19B
97.03%1.23B
110.62%1.18B
Net profit from continuing operation
10.59%439.82M
7.66%358.31M
9.02%220.44M
-58.74%491.01M
-67.79%397.69M
-71.68%332.82M
-77.57%202.21M
83.81%1.19B
97.03%1.23B
110.62%1.18B
Net income from discontinuing operating
----
----
----
---3.58M
----
----
----
----
----
----
Less:Minority Profit
282.73%3.88M
249.68%2.51M
243.94%2.11M
97.17%-196.42K
60.16%-2.12M
41.13%-1.68M
18.45%-1.47M
-274.78%-6.94M
-697.92%-5.33M
-227.87%-2.85M
Net profit of parent company owners
9.04%435.94M
6.37%355.8M
7.20%218.33M
-59.26%487.62M
-67.75%399.81M
-71.60%334.5M
-77.46%203.68M
88.68%1.2B
97.67%1.24B
111.98%1.18B
Earning per share
Basic earning per share
3.30%0.94
2.63%0.78
6.52%0.49
-59.41%1.1
-67.62%0.91
-71.54%0.76
-77.56%0.46
89.51%2.71
97.89%2.81
111.90%2.67
Diluted earning per share
3.30%0.94
2.63%0.78
6.52%0.49
-59.41%1.1
-67.62%0.91
-71.54%0.76
-77.56%0.46
89.51%2.71
97.89%2.81
111.90%2.67
Other composite income
-110.05%-222.87K
-61.49%736.51K
5.66%413.48K
-151.84%-109.99M
-79.64%2.22M
-57.68%1.91M
-80.12%391.33K
-223.20%-43.67M
2,422.29%10.89M
789.91%4.52M
Other composite income of parent company owners
-110.05%-222.87K
-61.49%736.51K
5.66%413.48K
-151.84%-109.99M
-79.64%2.22M
-57.68%1.91M
-80.12%391.33K
-223.20%-43.67M
2,422.29%10.89M
789.91%4.52M
Total composite income
9.92%439.59M
7.26%359.05M
9.01%220.86M
-67.08%377.44M
-67.89%399.9M
-71.62%334.74M
-77.58%202.6M
71.62%1.15B
98.92%1.25B
111.68%1.18B
Total composite income of parent company owners
8.38%435.71M
5.98%356.54M
7.19%218.75M
-67.26%377.64M
-67.86%402.03M
-71.55%336.42M
-77.46%204.07M
72.18%1.15B
99.56%1.25B
113.04%1.18B
Total composite income of minority owners
282.73%3.88M
249.68%2.51M
243.94%2.11M
97.17%-196.42K
60.16%-2.12M
41.13%-1.68M
18.45%-1.47M
-274.78%-6.94M
-697.92%-5.33M
-227.87%-2.85M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 8.83%2.18B5.82%1.58B3.54%861.09M-51.33%2.76B-57.32%2B-63.09%1.49B-68.32%831.63M69.01%5.68B87.32%4.7B117.30%4.03B
Operating revenue 8.83%2.18B5.82%1.58B3.54%861.09M-51.33%2.76B-57.32%2B-63.09%1.49B-68.32%831.63M69.01%5.68B87.32%4.7B117.30%4.03B
Other operating revenue -----50.13%1.92M-----24.25%5.22M-----41.70%3.85M-----3.11%6.89M----38.95%6.6M
Total operating cost 6.21%1.72B3.35%1.18B0.28%609.78M-47.01%2.29B-51.44%1.62B-57.58%1.15B-59.46%608.06M57.09%4.33B75.23%3.33B112.25%2.7B
Operating cost 7.08%797.67M3.53%561.7M0.54%290.15M-62.22%1.03B-65.58%744.9M-69.04%542.55M-69.54%288.59M96.02%2.74B151.46%2.16B202.20%1.75B
Operating tax surcharges 28.71%7.25M22.26%5.17M48.62%3.04M-31.63%12.17M-47.30%5.63M-50.56%4.23M-42.78%2.04M77.41%17.8M58.25%10.69M70.24%8.55M
Operating expense 1.30%472.01M0.95%318.5M9.45%159.81M-30.08%649.99M-30.87%465.93M-43.47%315.5M-58.21%146.02M44.28%929.61M24.42%673.97M53.54%558.11M
Administration expense 1.65%153.22M1.07%107.38M-8.68%58.49M-0.32%227.13M-23.38%150.73M-29.74%106.24M-12.89%64.05M-14.32%227.85M5.56%196.72M24.46%151.23M
Financial expense 227.46%14.4M56.70%-5.8M-155.96%-7.25M-817.68%-6.41M60.48%-11.3M-88.51%-13.39M67.60%12.96M-101.43%-697.96K-209.34%-28.59M-132.07%-7.1M
-Interest expense (Financial expense) 0.66%21.63M2.58%15.09M-10.42%7.14M-7.99%29.93M-4.81%21.49M-0.04%14.71M6.85%7.98M17.21%32.53M4.79%22.58M3.27%14.71M
-Interest Income (Financial expense) -7.43%-16.32M-45.93%-13.18M-108.50%-5.27M-435.67%-27.61M-265.23%-15.19M-121.92%-9.03M-224.51%-2.53M-70.87%-5.15M-150.37%-4.16M-205.02%-4.07M
Research and development 4.51%271.18M3.45%197.31M11.80%105.55M-9.75%378M-16.14%259.47M-19.91%190.74M-20.18%94.4M7.09%418.84M11.85%309.4M31.82%238.15M
Credit Impairment Loss -1,943.83%-18.1M-845.04%-15.27M-368.29%-8.46M92.91%-1.5M92.74%-885.39K85.44%-1.62M97.79%-1.81M4.18%-21.14M8.93%-12.2M10.97%-11.1M
Asset Impairment Loss ------------85.41%-11.52M-------------1,244.43%-78.97M--------
Other net revenue -55.95%32.47M-64.29%16.23M-88.63%962.56K357.37%78.88M13.06%73.72M27.21%45.45M110.99%8.47M-80.23%17.25M-19.05%65.2M-36.55%35.73M
Fair value change income 71.62%24.42M5,272.86%15.57M--867.58K15.51%14.8M281.58%14.23M-98.04%289.84K----21.42%12.81M--3.73M--14.81M
Invest income -92.58%1.96M-105.45%-1.21M81.08%2.96M-47.97%31.1M-23.74%26.48M83.34%22.22M-39.81%1.63M25.92%59.77M-27.69%34.72M-60.16%12.12M
-Including: Investment income associates -305.48%-12.42M-580.74%-7.34M-669.69%-3M-233.77%-4.33M-2,264.09%-3.06M73.99%-1.08M66.39%-390.3K156.38%3.24M-96.20%141.57K-248.87%-4.14M
Asset deal income 1,434.58%736.98K--------100.77%80.14K-8,757.56%-55.22K-4,937.69%-55.22K---59.91K-183,304.02%-10.4M-99.68%637.85-99.28%1.14K
Other revenue -30.95%23.45M-30.32%17.14M-35.62%5.6M-16.77%45.92M-12.83%33.95M23.68%24.6M315.37%8.7M-3.45%55.17M-14.82%38.95M-47.91%19.89M
Operating profit 7.64%498.11M4.90%407.22M8.72%252.27M-59.85%549.14M-67.76%462.77M-71.63%388.22M-77.86%232.04M97.68%1.37B108.18%1.44B113.82%1.37B
Add:Non operating Income -49.40%1.07M-44.42%705.83K-65.58%228.83K16.58%3.55M126.48%2.12M168.03%1.27M10.43%664.73K8.17%3.04M-6.61%935.96K-41.79%473.82K
Less:Non operating expense 17.45%6.34M-10.66%2.58M-24.54%897.9K90.81%11.92M-11.85%5.4M0.41%2.89M31.16%1.19M-56.07%6.25M43.14%6.13M4.51%2.88M
Total profit 7.26%492.84M4.85%405.35M8.68%251.6M-60.37%540.76M-67.87%459.49M-71.70%386.6M-77.91%231.51M100.52%1.36B108.42%1.43B114.10%1.37B
Less:Income tax cost -14.21%53.02M-12.54%47.03M6.35%31.16M-69.42%53.33M-68.39%61.8M-71.82%53.77M-79.95%29.3M264.04%174.41M228.27%195.48M138.34%190.8M
Net profit 10.59%439.82M7.66%358.31M9.02%220.44M-59.04%487.43M-67.79%397.69M-71.68%332.82M-77.57%202.21M88.14%1.19B97.03%1.23B110.62%1.18B
Net profit from continuing operation 10.59%439.82M7.66%358.31M9.02%220.44M-58.74%491.01M-67.79%397.69M-71.68%332.82M-77.57%202.21M83.81%1.19B97.03%1.23B110.62%1.18B
Net income from discontinuing operating ---------------3.58M------------------------
Less:Minority Profit 282.73%3.88M249.68%2.51M243.94%2.11M97.17%-196.42K60.16%-2.12M41.13%-1.68M18.45%-1.47M-274.78%-6.94M-697.92%-5.33M-227.87%-2.85M
Net profit of parent company owners 9.04%435.94M6.37%355.8M7.20%218.33M-59.26%487.62M-67.75%399.81M-71.60%334.5M-77.46%203.68M88.68%1.2B97.67%1.24B111.98%1.18B
Earning per share
Basic earning per share 3.30%0.942.63%0.786.52%0.49-59.41%1.1-67.62%0.91-71.54%0.76-77.56%0.4689.51%2.7197.89%2.81111.90%2.67
Diluted earning per share 3.30%0.942.63%0.786.52%0.49-59.41%1.1-67.62%0.91-71.54%0.76-77.56%0.4689.51%2.7197.89%2.81111.90%2.67
Other composite income -110.05%-222.87K-61.49%736.51K5.66%413.48K-151.84%-109.99M-79.64%2.22M-57.68%1.91M-80.12%391.33K-223.20%-43.67M2,422.29%10.89M789.91%4.52M
Other composite income of parent company owners -110.05%-222.87K-61.49%736.51K5.66%413.48K-151.84%-109.99M-79.64%2.22M-57.68%1.91M-80.12%391.33K-223.20%-43.67M2,422.29%10.89M789.91%4.52M
Total composite income 9.92%439.59M7.26%359.05M9.01%220.86M-67.08%377.44M-67.89%399.9M-71.62%334.74M-77.58%202.6M71.62%1.15B98.92%1.25B111.68%1.18B
Total composite income of parent company owners 8.38%435.71M5.98%356.54M7.19%218.75M-67.26%377.64M-67.86%402.03M-71.55%336.42M-77.46%204.07M72.18%1.15B99.56%1.25B113.04%1.18B
Total composite income of minority owners 282.73%3.88M249.68%2.51M243.94%2.11M97.17%-196.42K60.16%-2.12M41.13%-1.68M18.45%-1.47M-274.78%-6.94M-697.92%-5.33M-227.87%-2.85M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data